NTRA LAWSUIT ALERT: Levi & Korsinsky Notifies Natera, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, June 9, 2022

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Natera investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of a class of all persons and entities who purchased or otherwise acquired Natera common stock between February 26, 2020, and April 19, 2022, inclusive.  Follow the link below to get more information and be contacted by a member of our team:

https://www.zlk.com/pslra-1/natera-inc-loss-submission-form?prid=28233&wire=4

NTRA investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) the Company's non-invasive prenatal test, Panorama, was not reliable and resulted in high rates of false positives; (2) the Company's screening test for kidney transplant failure, Prospera, did not have superior precision compared to competing tests; (3) as a result of defendants' false and misleading claims about Natera's technology, the Company was exposed to substantial legal and regulatory risks; (4) Natera relied upon deceptive sales and billing practices to drive its revenue growth; and (5) as a result of the foregoing, defendants' statements about the company's business, operations, and prospects lacked a reasonable basis.

WHAT'S NEXT? If you suffered a loss in Natera during the relevant time frame, you have until June 27, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.